Insmed Inc (INSM)vsZura Bio Limited Class A Ordinary Shares (ZURA)
INSM
Insmed Inc
$148.31
+6.59%
HEALTHCARE · Cap: $29.99B
ZURA
Zura Bio Limited Class A Ordinary Shares
$5.62
+4.46%
HEALTHCARE · Cap: $510.46M
Smart Verdict
WallStSmart Research — data-driven comparison
ZURA leads profitability with a 0.0% profit margin vs -2.1%. INSM earns a higher WallStSmart Score of 39/100 (F).
INSM
Hold39
out of 100
Grade: F
ZURA
Avoid24
out of 100
Grade: F
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
No standout strengths identified
No standout strengths identified
Areas to Watch
1.5% revenue growth
0.0% earnings growth
Trading at 43.0x book value
ROE of -2.5% — below average capital efficiency
0.0% revenue growth
0.0% earnings growth
Smaller company, higher risk/reward
0.0% margin — thin
Comparative Analysis Report
WallStSmart ResearchBull Case : INSM
PEG of 1.09 suggests the stock is reasonably priced for its growth.
Bull Case : ZURA
ZURA has a balanced fundamental profile.
Bear Case : INSM
The primary concerns for INSM are Revenue Growth, EPS Growth, Price/Book.
Bear Case : ZURA
The primary concerns for ZURA are Revenue Growth, EPS Growth, Market Cap.
Key Dynamics to Monitor
INSM profiles as a turnaround stock while ZURA is a value play — different risk/reward profiles.
INSM carries more volatility with a beta of 1.17 — expect wider price swings.
INSM is growing revenue faster at 1.5% — sustainability is the question.
ZURA generates stronger free cash flow (-22M), providing more financial flexibility.
Bottom Line
INSM scores higher overall (39/100 vs 24/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Insmed Inc
HEALTHCARE · BIOTECHNOLOGY · USA
Insmed Incorporated, a biopharmaceutical company, develops and markets therapies for patients with rare and serious diseases. The company is headquartered in Bridgewater, New Jersey.
Zura Bio Limited Class A Ordinary Shares
HEALTHCARE · BIOTECHNOLOGY · USA
Zura Bio Limited (Ticker: ZURA) is an innovative biotechnology company specializing in the development of groundbreaking therapies for autoimmune disorders and rare diseases. With a strong pipeline of drug candidates and a commitment to rigorous clinical trials, Zura Bio leverages advanced research methodologies to bring solutions to patients with unmet medical needs. The company is led by an experienced management team and has established strategic partnerships, positioning it favorably within the biopharmaceutical sector and enhancing its potential to drive value for investors in an evolving market landscape.
Compare with Other BIOTECHNOLOGY Stocks
Want to dig deeper into these stocks?